John J. Fulton Co. v. Federal Trade Commission

HEALY, Circuit Judge.

In a proceeding before the Federal Trade Commission, here under review, petitioner was ordered to desist from advertising its product, Uvursin, as an effective treatment for diabetes.

Petitioner advertised the preparation in medical journals and in circulars distributed to the profession. Typical representations determined by the Commission to be false were that Uvursin “is a mild and innocuous oral treatment for diabetes mellitus”; that it is an efficacious treatment; that diabetic gangren.e “yields to Uvursin”; and that the product “is being recognized as the preferred…